Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2014 | Series D | $59.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Amherst Fund | — | Series D |